119 related articles for article (PubMed ID: 16575890)
1. Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?
van der Vleuten GM; Hijmans A; Heil S; Blom HJ; Stalenhoef AF; de Graaf J
Am J Med Genet A; 2006 May; 140(9):1010-2. PubMed ID: 16575890
[No Abstract] [Full Text] [Related]
2. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
Coon H; Singh N; Dunn D; Eckfeldt JH; Province MA; Hopkins PN; Weiss R; Hunt SC; Leppert MF;
Atherosclerosis; 2004 Jun; 174(2):357-62. PubMed ID: 15136067
[TBL] [Abstract][Full Text] [Related]
3. A mouse model with features of familial combined hyperlipidemia.
Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR
Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and expression of familial combined hyperlipidemia in childhood.
Cortner JA; Coates PM; Gallagher PR
J Pediatr; 1990 Apr; 116(4):514-9. PubMed ID: 2319396
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
[TBL] [Abstract][Full Text] [Related]
6. Carotid distension and distensibility impairment in individuals affected by familial combined hyperlipidemia.
Montalcini T; Gorgone G; Gazzaruso C; Pujia A
Atherosclerosis; 2010 Sep; 212(1):177-80. PubMed ID: 20542511
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Haffner SM; Kushwaha RS; Hazzard WR
Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
[TBL] [Abstract][Full Text] [Related]
8. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
9. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
Bredie SJ; van Drongelen J; Kiemeney LA; Demacker PN; Beaty TH; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):834-40. PubMed ID: 9157945
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia.
van der Vleuten GM; Hijmans A; Kluijtmans LA; Blom HJ; Stalenhoef AF; de Graaf J
Am J Med Genet A; 2004 Sep; 130A(1):73-5. PubMed ID: 15368498
[TBL] [Abstract][Full Text] [Related]
11. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
Tatò F; Keller C; Wolfram G
Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
[TBL] [Abstract][Full Text] [Related]
12. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
[TBL] [Abstract][Full Text] [Related]
13. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
14. Positional cloning of the combined hyperlipidemia gene Hyplip1.
Bodnar JS; Chatterjee A; Castellani LW; Ross DA; Ohmen J; Cavalcoli J; Wu C; Dains KM; Catanese J; Chu M; Sheth SS; Charugundla K; Demant P; West DB; de Jong P; Lusis AJ
Nat Genet; 2002 Jan; 30(1):110-6. PubMed ID: 11753387
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
16. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
17. [Apolipoprotein E gene expression in peripheral blood monocyte in children with obesity].
Xiang W; Ma YL; Chen C; Fu SM; Yang JF; Zhao SP; Guo DX; Zhao DC; Nie S; Wang FL
Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):755-60. PubMed ID: 14731357
[TBL] [Abstract][Full Text] [Related]
18. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.
Liacouras CA; Coates PM; Gallagher PR; Cortner JA
J Pediatr; 1993 Mar; 122(3):477-82. PubMed ID: 8441109
[TBL] [Abstract][Full Text] [Related]
19. A study of familial combined hyperlipidemia in 11 families.
Das SK; Chandra M; Shukla RN; Nityanand S; Agarwal SS
Indian J Med Res; 1983 Nov; 78():665-9. PubMed ID: 6671713
[No Abstract] [Full Text] [Related]
20. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
